risperidone has been researched along with Glial Cell Tumors in 7 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study examines the effects of antipsychotic drugs, haloperidol and risperidone, on the expression of HSP70 produced by MK-801 in rat C6 glioma cells." | 7.74 | Effects of haloperidol and risperidone on the expression of heat shock protein 70 in MK-801-treated rat C6 glioma cells. ( Chai, YG; Choi, J; Choi, MR; Kim, D; Kim, DJ; Kim, SH; Lee, JS; Park, YC; Roh, K; Roh, S; Yang, BH, 2008) |
| " We used two-dimensional gel electrophoresis coupled with MALDI-TOF/TOF mass spectrometry protein identification to analyze differentially expressed proteins in haloperidol-, risperidone-, and clozapine-treated C6 glioma cells." | 3.79 | Two-dimensional gel electrophoresis revealed antipsychotic drugs induced protein expression modulations in C6 glioma cells. ( Chen, ML, 2013) |
| " The present study examines the effects of antipsychotic drugs, haloperidol and risperidone, on the expression of HSP70 produced by MK-801 in rat C6 glioma cells." | 3.74 | Effects of haloperidol and risperidone on the expression of heat shock protein 70 in MK-801-treated rat C6 glioma cells. ( Chai, YG; Choi, J; Choi, MR; Kim, D; Kim, DJ; Kim, SH; Lee, JS; Park, YC; Roh, K; Roh, S; Yang, BH, 2008) |
| "Risperidone can activate the Akt-GSK3β signaling pathway in the U251 cells, and PI3K is a common regulatory site in Akt-GSK3β signaling and D2 receptor gene expression." | 1.40 | [Regulation of PI3K-Akt-GSK3β signaling pathway in U251 cells by risperidone]. ( Gu, X; Li, T; Liang, L; Ma, X; Wang, Y; Wei, J; Xiang, B, 2014) |
| "Alniditan is a new migraine-abortive agent." | 1.29 | Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin ( Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leysen, JE | 1 |
| Gommeren, W | 1 |
| Heylen, L | 1 |
| Luyten, WH | 1 |
| Van de Weyer, I | 1 |
| Vanhoenacker, P | 1 |
| Haegeman, G | 1 |
| Schotte, A | 1 |
| Van Gompel, P | 1 |
| Wouters, R | 1 |
| Lesage, AS | 1 |
| Liang, L | 1 |
| Wang, Y | 1 |
| Wei, J | 1 |
| Gu, X | 1 |
| Xiang, B | 1 |
| Ma, X | 1 |
| Li, T | 1 |
| Roh, K | 1 |
| Roh, S | 1 |
| Yang, BH | 1 |
| Lee, JS | 1 |
| Chai, YG | 1 |
| Choi, MR | 1 |
| Park, YC | 1 |
| Kim, DJ | 1 |
| Kim, D | 1 |
| Choi, J | 1 |
| Kim, SH | 1 |
| Chen, ML | 1 |
| de Souza, DF | 1 |
| Wartchow, K | 1 |
| Hansen, F | 1 |
| Lunardi, P | 1 |
| Guerra, MC | 1 |
| Nardin, P | 1 |
| Gonçalves, CA | 1 |
| Kagaya, A | 1 |
| Motohashi, N | 1 |
| Kugaya, A | 1 |
| Yamaji, T | 1 |
| Hayashi, T | 1 |
| Okamoto, Y | 1 |
| Shinno, H | 1 |
| Takebayashi, M | 1 |
| Uchitomi, Y | 1 |
| Yamawaki, S | 1 |
| Griffon, N | 1 |
| Pilon, C | 1 |
| Sautel, F | 1 |
| Schwartz, JC | 1 |
| Sokoloff, P | 1 |
7 other studies available for risperidone and Glial Cell Tumors
| Article | Year |
|---|---|
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorde | 1996 |
[Regulation of PI3K-Akt-GSK3β signaling pathway in U251 cells by risperidone].
Topics: Antipsychotic Agents; Cell Line, Tumor; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase | 2014 |
Effects of haloperidol and risperidone on the expression of heat shock protein 70 in MK-801-treated rat C6 glioma cells.
Topics: Animals; Cell Line, Tumor; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagoni | 2008 |
Two-dimensional gel electrophoresis revealed antipsychotic drugs induced protein expression modulations in C6 glioma cells.
Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Clozapine; Electrophoresis, Gel, Two-Dimensional; F | 2013 |
Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone.
Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Cytokines; Enzyme-Linked Immunosorbent Assay; Glial | 2013 |
Cyclic GMP generation mediated by 5-HT-2 receptors via nitric oxide-dependent pathway and its effect on the desensitization of 5-HT-2 receptors in C6 glioma cells.
Topics: Animals; Arginine; Calcium; Chelating Agents; Cyclic GMP; Dopamine Antagonists; Edetic Acid; Egtazic | 1995 |
Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
Topics: Animals; Antipsychotic Agents; Calcium; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; DNA | 1996 |